Skip to content
Screener

Black Diamond Therapeutics, Inc. BDTX Q1 2025 earnings

Reported May 12, 2025 · Before market open

Revenue$70.0MBeat by $42.0M
EPS$0.98Beat by $0.96
Revenue estimate$28.0M
EPS estimate$0.02

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$8.3M
EPS estimate-$0.06

FAQ

When did Black Diamond Therapeutics, Inc. report Q1 2025 earnings?
Black Diamond Therapeutics, Inc. (BDTX) reported Q1 2025 earnings on May 12, 2025 before market open.
What were Black Diamond Therapeutics, Inc.'s Q1 2025 revenue and EPS?
Black Diamond Therapeutics, Inc. reported revenue of $70.0M and eps of $0.98 for Q1 2025.
Did Black Diamond Therapeutics, Inc. beat estimates in Q1 2025?
Revenue beat the consensus estimate of $28.0M by $42.0M. EPS beat the consensus estimate of $0.02 by $0.96.
Where can I find Black Diamond Therapeutics, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001701541-25-000021) and the 10-Q periodic report (0001701541-25-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.